Medication program persistence and engagement : January 2026 analysis of 30,239 Noom GLP-1Rx Program members who started a GLP-1Rx plan, evaluating program persistence by engagement quartile
And no matter how many online courses you take, youll NEVER get the same education as you would from learning from other practitioners on the front lines of medical application
Most private clinics, pharmacies, and online prescribers, like those at Longridge Travel Health Clinic will approve Wegovy if: You are an adult (18 or over), and Your BMI is 30 or above Your BMI is 27 or above with at least one weight-related condition (such as high cholesterol, raised blood pressure, type 2 diabetes, or obstructive sleep apnoea)
The newlyapproved innovative drug will be suitable for obese or overweight patients withan initial BMI of 30kg/m2 or greater or between 27kg/m2 and 30kg/m2 with atleast one weight-related comorbiditis
2/ How GLP-1s help manage type 2 diabetes 3/ GLP-1 agonists and appetite 4/ How to amplify GLP-1 weight loss 5/ GLP-1s and food noise 6/ GLP-1s and heart and kidney health 7/ GLP-1s and mood 8/ GLP-1s and addiction 9/ GLP-1s and sleep 10/ GLP-1s and cancer 11/ The bottom line Its easy to miss the full story of GLP-1s